Bohn et al. have indicated that combinatorial inhibition of VEGF and Angiopoietin-2 (Ang2) decreased lesion permeability and reduced BMs of breast cancer burden in animal model [163]. This evidence concerns the gene ANGPT2 and breast carcinoma.